当前位置: X-MOL 学术Antivir. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand.
Antiviral Therapy ( IF 1.2 ) Pub Date : 2022-8-28 , DOI: 10.1177/13596535221092182
European Pregnancy And Paediatric Infections Cohort Collaboration Eppicc , Alex Lyons 1 , Lindsay Thompson 1 , Elizabeth Chappell 1 , Luminita Ene 2 , Luisa Galli 3 , Tessa Goetghebuer 4 , Gonzague Jourdain 5, 6 , Antoni Noguera-Julian 7 , Christian R Kahlert 8 , Christoph Königs 9 , Pope Kosalaraksa 10 , Pagakrong Lumbiganon 10 , Magdalena Marczyńska 11 , Laura Marques 12 , Marissa Navarro 13, 14, 15, 16 , Lars Naver 17 , Liubov Okhonskaia 18 , Filipa Prata 19 , Thanyawee Puthanakit 20 , Jose T Ramos 21 , Anna Samarina 22 , Claire Thorne 23 , Evgeny Voronin 18 , Anna Turkova 1, 24 , Carlo Giaquinto 25 , Ali Judd 1 , Intira J Collins 1
Affiliation  

Etravirine (ETR) is approved as a component of second or third-line antiretroviral treatment (ART) for children living with HIV. We assessed the outcomes of ETR-based ART in children in routine care in Europe and Thailand.

中文翻译:

欧洲和泰国接受过治疗的艾滋病毒感染儿童和青少年基于依曲韦林的抗逆转录病毒治疗的结果。

依曲韦林 (ETR) 被批准作为艾滋病毒儿童二线或三线抗逆转录病毒治疗 (ART) 的组成部分。我们评估了欧洲和泰国接受常规护理的儿童基于 ETR 的 ART 的结果。
更新日期:2022-08-28
down
wechat
bug